安进公司是一家生物技术公司。该公司探索、开发、制造及销售人类治疗药品。该公司通过人类治疗药品业务运营。该公司销售的药品包括:Neulasta(pegfilgrastim),Aranesp(darbepoetin alfa)及EPOGEN(epoetin alfa)等促红细胞生成剂,Sensipar/Mimpara(cinacalcet),XGEVA(denosumab),Prolia(denosumab),NEUPOGEN(filgrastim),和Vectibix (panitumumab)、Nplate(romiplostim)及Corlanor(ivabradine)等。该公司专注于研发用于治疗肿瘤及血液病、心血管病、炎症、骨骼病、肾脏病及神经疾病等严重疾病的人类药物。该公司研发的处于第III阶段的产品包括用于发作性偏头痛的Erenumab,骨髓增生异常综合征的Aranesp,急性淋巴细胞白血病的BLINCYTO和转移性黑色素瘤的IMLYGIC。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| Robert A. Bradway | Chairman & CEO | 2013 | 63 |
| Robert A. Eckert | Lead Independent Director | 2016 | 72 |
| Gregory C. Garland | Independent Director | 2013 | 69 |
| Ellen J. Kullman | Independent Director | 2016 | 70 |
| Charles M. Holley | Independent Director | 2017 | 69 |
| Charles Elliott Sigal | Co-Chair of the Scientific Advisory Board | - | 74 |
| Jonathan S. Weissman | Co-Chair of the Scientific Advisory Board | 2026 | - |
| Tyler E. Jacks | Independent Director | 2012 | 65 |
| R. Sanders Williams | Member of Scientific Advisory Board of Cardiovascular & Metabolic | 2024 | 77 |
| Wanda M. Austin | Independent Director | 2017 | 72 |
| Brian J. Druker | Independent Director | 2018 | 70 |
| Amy E. Miles | Independent Director | 2020 | 59 |
| S. Omar Ishrak | Independent Director | 2021 | 70 |
| S. Gail Eckhardt | Member of Scientific Advisory Board of Oncology | 2022 | - |
| Michael V. Drake | Independent Director | 2022 | 74 |
| Diane J. Mathis | Member of Scientific Advisory Board of Inflammation | - | - |
| Lillian L. Siu | Member of Scientific Advisory Board of Oncology | 2022 | - |
| Emma Guttman-Yassky | Member of Scientific Advisory Board of Inflammation | 2022 | - |
| Alexander Marson | Member of Scientific Advisory Board of Inflammation | 2022 | - |
| Alexander Rudensky | Member of Scientific Advisory Board of Inflammation | 2022 | - |
| Arlene Sharpe | Member of Scientific Advisory Board of Inflammation | 2022 | - |
| Dean Sheppard | Member of Scientific Advisory Board of Inflammation | 2022 | - |
| Maria T. Abreu | Member of Scientific Advisory Board of Inflammation | 2022 | - |
| George Georgiou | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | 2023 | 67 |
| Siwen Hu-Lieskovan | Member of Scientific Advisory Board of Oncology | - | - |
| Marlene Rabinovitch | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | - |
| Benoit Van den Eynde | Member of Scientific Advisory Board of Oncology | - | - |
| Antoni Ribas | Member of Scientific Advisory Board of Oncology | - | 59 |
| Robert S. Negrin | Member of Scientific Advisory Board of Oncology | - | - |
| Andrew Mark Pardoll | Member of Scientific Advisory Board of Oncology | - | - |
| Dirk Jäger | Member of Scientific Advisory Board of Oncology | - | - |
| David Alan Kass | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | - |
| Daniel P. Kelly | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | - |
| Thomas Quertermous | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | 74 |
| Peter Libby | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | 78 |
| Jeffery D. Molkentin | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | - |
| Daniel Joshua Drucker | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | - |
| E. Dale Abel | Member of Scientific Advisory Board of Cardiovascular & Metabolic | - | - |
| Frank P. McCormick | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | - | 76 |
| David J. Anderson | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | - | - |
| Ronald M. Evans | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | - | 76 |
| Mary Earley Klotman | Independent Director | 2024 | 72 |
| Fabrice Andre | Member of Scientific Advisory Board of Oncology | - | - |
| Randy J. Seeley | Member of Scientific Advisory Board | 2025 | - |
| Viviana Gradinaru | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | 2026 | - |
| Eran Segal | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | 2026 | - |
| Philip Zamore | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | 2026 | - |
| David J. Mooney | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | 2026 | - |
| James Zou | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | 2026 | - |
| Patrick Hsu | Member of Scientific Advisory Board of Research Trends & Emerging Technologies | 2026 | - |